Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

The Company had cash of $2.8 million as at August 31, 2015 compared to $3.0 million as at May 31, 2015.

For the three months ended August 31, 2015, net cash flows provided from financing activities of $1.2 million, related principally to at-the-market issuances of 218,300 of our common shares sold on NASDAQ for gross proceeds of $0.7 million and net proceeds of $0.7 million, as well as $0.6 million related to the exercise of warrants, partially offset by capital lease and financing cost payments.

We believe our current cash position is sufficient to fund our currently projected operations to January 2016